Acute psychiatry Publications

Publications 2024

  1. Shafi DES, Jørgensen KN, Bjella T, Nesvåg R, Dieset I, Melle I, Andreassen OA, Jönsson EG (2024)
    Prescriptions of psychotropic and somatic medications among patients with severe mental disorders and healthy controls in a naturalistic study
    Nord J Psychiatry, 78 (3), 212-219
    DOI 10.1080/08039488.2024.2305806, PubMed 38306243

Publications 2023

  1. Gachabayov M, Bergamaschi R, Wasmuth H, Faerden A, Javadov M, Cianchi F, Barnajian M, Popa DE, Lee H (2023)
    Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
    Tech Coloproctol, 27 (12), 1411-1412
    DOI 10.1007/s10151-023-02866-3, PubMed 37812263
  2. Lien L, Færden A (2023)
    [Mental health aid to Ukraine]
    Tidsskr Nor Laegeforen, 143 (6)
    DOI 10.4045/tidsskr.23.0205, PubMed 37097240
  3. Lyngstad SH, Lyne JP, Ihler HM, van der Meer L, Færden A, Melle I (2023)
    Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders
    Schizophr Bull, 49 (5), 1099-1104
    DOI 10.1093/schbul/sbad070, PubMed 37193675
  4. Reponen EJ, Ueland T, Rokicki J, Bettella F, Aas M, Werner MCF, Dieset I, Steen NE, Andreassen OA, Tesli M (2023)
    Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers
    Eur Arch Psychiatry Clin Neurosci, 274 (5), 1223-1230
    DOI 10.1007/s00406-023-01591-0, PubMed 37145175
  5. Schjøtt-Pedersen O, Seierstad A, Evensen S, Horgen Evensen J, Færden A, Lunde Gjerstad C, Fadler Martinsen F, Sørgård KM, Ullevoldsæter Lystad J (2023)
    Lockdown during the early phase of Covid-19 - effects on specialized mental health services and vocational activities for patients with psychotic disorders
    Nord J Psychiatry, 77 (8), 760-767
    DOI 10.1080/08039488.2023.2240301, PubMed 37534458

Publications 2022

  1. Barrow LFM, Faerden A (2022)
    Barriers to accessing mental health services in The Gambia: patients'/family members' perspectives
    BJPsych Int, 19 (2), 38-41
    DOI 10.1192/bji.2021.26, PubMed 35532422
  2. Engen MJ, Vaskinn A, Melle I, Færden A, Lyngstad SH, Flaaten CB, Widing LH, Wold KF, Åsbø G, Haatveit B, Simonsen C, Ueland T (2022)
    Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study
    Front Psychiatry, 13, 841057
    DOI 10.3389/fpsyt.2022.841057, PubMed 35401286
  3. Faerden A, Rosenqvist C, Håkansson M, Strøm-Gundersen E, Stav Å, Svartsund J, Røssæg T, Davik N, Kvarstein E, Pedersen G, Dieset I, Nyrud AQ, Weedon-Fekjær H, Kistorp KM (2022)
    Environmental Transformations Enhancing Dignity in an Acute Psychiatric Ward: Outcome of a User-Driven Service Design Project
    HERD, 16 (2), 55-72
    DOI 10.1177/19375867221136558, PubMed 36567605
  4. Hjell G, Szabo A, Mørch-Johnsen L, Holst R, Tesli N, Bell C, Fischer-Vieler T, Werner MCF, Lunding SH, Ormerod MBEG, Johansen IT, Dieset I, Djurovic S, Melle I, Ueland T, Andreassen OA, Steen NE, Haukvik UK (2022)
    Interleukin-18 signaling system links to agitation in severe mental disorders
    Psychoneuroendocrinology, 140, 105721
    DOI 10.1016/j.psyneuen.2022.105721, PubMed 35301151
  5. Lockertsen Ø, Løvhaug L, Davik NK, Bølgen BR, Færden A, Skarstein S (2022)
    Second-year undergraduate nursing students' experiences with clinical simulation training in mental health clinical practice: A focus group study
    Nurse Educ Pract, 66, 103534
    DOI 10.1016/j.nepr.2022.103534, PubMed 36563598

Publications 2021

  1. Dieset I, Løvhaug L, Selle M, Kolseth A, Smeland OB, Færden A (2021)
    Lessons learned from a cross-sectional survey among patients and staff in an acute psychiatric unit during an ongoing pandemic outbreak
    Psychiatry Res, 298, 113779
    DOI 10.1016/j.psychres.2021.113779, PubMed 33561619
  2. Fjukstad KK, Athanasiu L, Bahrami S, O'Connell KS, van der Meer D, Bettella F, Dieset I, Steen NE, Djurovic S, Spigset O, Andreassen OA (2021)
    Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study
    Pharmacogenomics J, 21 (5), 574-585
    DOI 10.1038/s41397-021-00234-8, PubMed 33824429
  3. Reponen EJ, Tesli M, Dieset I, Steen NE, Vedal TSJ, Szabo A, Werner MCF, Lunding SH, Johansen IT, Rødevand LN, Andreassen OA, Ueland T (2021)
    Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
    Front Psychiatry, 12, 623192
    DOI 10.3389/fpsyt.2021.623192, PubMed 34122163

Publications 2020

  1. Færden A, Bølgen B, Løvhaug L, Thoresen C, Dieset I (2020)
    Patient satisfaction and acute psychiatric inpatient treatment
    Nord J Psychiatry, 74 (8), 577-584
    DOI 10.1080/08039488.2020.1764620, PubMed 32427019
  2. Haatveit B, Mørch-Johnsen L, Alnæs D, Engen MJ, Lyngstad SH, Færden A, Agartz I, Ueland T, Melle I (2020)
    Divergent relationship between brain structure and cognitive functioning in patients with prominent negative symptomatology
    Psychiatry Res Neuroimaging, 307, 111233
    DOI 10.1016/j.pscychresns.2020.111233, PubMed 33340940
  3. Lockertsen O, Varvin S, Faerden A, Eriksen BMS, Roaldset JO, Procter NG, Vatnar SKB (2020)
    Risk assessment of imminent violence in acute psychiatry: a step towards an extended model
    J. Forensic Psychiatry Psychol., 31 (1), 41-63
    DOI 10.1080/14789949.2019.1663898
  4. Lockertsen Ø, Varvin S, Færden A, Vatnar SKB (2020)
    Short-term risk assessments in an acute psychiatric inpatient setting: A re-examination of the Brøset Violence Checklist using repeated measurements - Differentiating violence characteristics and gender
    Arch Psychiatr Nurs, 35 (1), 17-26
    DOI 10.1016/j.apnu.2020.11.003, PubMed 33593511
  5. Lyngstad SH, Bettella F, Aminoff SR, Athanasiu L, Andreassen OA, Faerden A, Melle I (2020)
    Associations between schizophrenia polygenic risk and apathy in schizophrenia spectrum disorders and healthy controls
    Acta Psychiatr Scand, 141 (5), 452-464
    DOI 10.1111/acps.13167, PubMed 32091622
  6. Lyngstad SH, Gardsjord ES, Engen MJ, Haatveit B, Ihler HM, Wedervang-Resell K, Simonsen C, Melle I, Færden A (2020)
    Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study
    Eur Arch Psychiatry Clin Neurosci, 270 (6), 709-722
    DOI 10.1007/s00406-020-01112-3, PubMed 32130475
  7. Reponen EJ, Dieset I, Tesli M, Mørch RH, Aas M, Vedal TSJ, Haug E, Drange OK, Steen NE, Hope S, Szabo A, Gohar SM, Wedervang-Resell K, Djurovic S, Melle I, Aukrust P, Andreassen OA, Ueland T (2020)
    Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
    Front Psychiatry, 11, 672
    DOI 10.3389/fpsyt.2020.00672, PubMed 32754070
  8. Szabo A, Akkouh IA, Ueland T, Lagerberg TV, Dieset I, Bjella T, Aukrust P, Le Hellard S, Stavrum AK, Melle I, Andreassen OA, Djurovic S (2020)
    Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
    Front Psychiatry, 11, 642
    DOI 10.3389/fpsyt.2020.00642, PubMed 32714224

Publications 2019

  1. Engen MJ, Simonsen C, Melle I, Færden A, Lyngstad SH, Haatveit B, Vaskinn A, Ueland T (2019)
    Cognitive functioning in patients with first-episode psychosis stratified by level of negative symptoms: A 1-year follow-up study
    Psychiatry Res, 281, 112554
    DOI 10.1016/j.psychres.2019.112554, PubMed 31499342
  2. Gohar SM, Dieset I, Steen NE, Mørch RH, Vedal TSJ, Reponen EJ, Steen VM, Andreassen OA, Melle I (2019)
    Association between leptin levels and severity of suicidal behaviour in schizophrenia spectrum disorders
    Acta Psychiatr Scand, 139 (5), 464-471
    DOI 10.1111/acps.13019, PubMed 30848483
  3. Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E (2019)
    Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
    Front Psychiatry, 9, 753
    DOI 10.3389/fpsyt.2018.00753, PubMed 30766494
  4. Mørch RH, Dieset I, Færden A, Reponen EJ, Hope S, Hoseth EZ, Gardsjord ES, Aas M, Iversen T, Joa I, Morken G, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA (2019)
    Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors
    Psychol Med, 49 (10), 1749-1757
    DOI 10.1017/S0033291718004142, PubMed 30688187
  5. Mørch RH, Dieset I, Færden A, Reponen EJ, Hope S, Hoseth EZ, Gardsjord ES, Aas M, Iversen T, Joa I, Morken G, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA (2019)
    Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors - ERRATUM
    Psychol Med, 49 (10), 1758
    DOI 10.1017/S0033291719000291, PubMed 30803457
  6. Quintana DS, Rokicki J, van der Meer D, Alnæs D, Kaufmann T, Córdova-Palomera A, Dieset I, Andreassen OA, Westlye LT (2019)
    Oxytocin pathway gene networks in the human brain
    Nat Commun, 10 (1), 668
    DOI 10.1038/s41467-019-08503-8, PubMed 30737392
  7. Rødevand L, Steen NE, Elvsåshagen T, Quintana DS, Reponen EJ, Mørch RH, Lunding SH, Vedal TSJ, Dieset I, Melle I, Lagerberg TV, Andreassen OA (2019)
    Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade
    Acta Psychiatr Scand, 139 (4), 348-360
    DOI 10.1111/acps.13008, PubMed 30697685
  8. Simonsen C, Aminoff SR, Vaskinn A, Barrett EA, Faerden A, Ueland T, Andreassen OA, Romm KL, Melle I (2019)
    Perceived and experienced stigma in first-episode psychosis: A 1-year follow-up study
    Compr Psychiatry, 95, 152134
    DOI 10.1016/j.comppsych.2019.152134, PubMed 31669787
  9. Steen NE, Dieset I, Hope S, Vedal TSJ, Smeland OB, Matson W, Kaddurah-Daouk R, Agartz I, Melle I, Djurovic S, Jönsson EG, Bogdanov M, Andreassen OA (2019)
    Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders
    Psychol Med, 50 (4), 595-606
    DOI 10.1017/S0033291719000400, PubMed 30867076
  10. Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2019)
    Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI
    Psychoneuroendocrinology, 103, 87-95
    DOI 10.1016/j.psyneuen.2019.01.001, PubMed 30659986
  11. Weisser KH, Diseth TH, Boye B, Faerden A, Ekeberg Ø (2019)
    Examining the organization and quality of the psychiatric consultative service in Norway
    Nord J Psychiatry, 73 (1), 9-15
    DOI 10.1080/08039488.2018.1525426, PubMed 30661436

Publications 2018

  1. Dieset I, Mørch RH, Hope S, Hoseth EZ, Reponen EJ, Gran JM, Aas M, Michelsen AE, Reichborn-Kjennerud T, Nesvåg R, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA (2018)
    An association between YKL-40 and type 2 diabetes in psychotic disorders
    Acta Psychiatr Scand, 139 (1), 37-45
    DOI 10.1111/acps.12971, PubMed 30328100
  2. Eriksen BMS, Færden A, Lockertsen Ø, Bjørkly S, Roaldset JO (2018)
    Predictive validity and gender differences in a biopsychosocial model of violence risk assessment in acute psychiatry
    Psychiatry Res, 264, 270-280
    DOI 10.1016/j.psychres.2018.04.021, PubMed 29655971
  3. Faerden A, Lyngstad SH, Simonsen C, Ringen PA, Papsuev O, Dieset I, Andreassen OA, Agartz I, Marder SR, Melle I (2018)
    Reliability and validity of the self-report version of the apathy evaluation scale in first-episode Psychosis: Concordance with the clinical version at baseline and 12 months follow-up
    Psychiatry Res, 267, 140-147
    DOI 10.1016/j.psychres.2018.05.065, PubMed 29906681
  4. Gohar SM, Dieset I, Steen NE, Mørch RH, Iversen TS, Steen VM, Andreassen OA, Melle I (2018)
    Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders
    Eur Arch Psychiatry Clin Neurosci, 269 (7), 795-802
    DOI 10.1007/s00406-018-0897-z, PubMed 29721726
  5. Hoseth EZ, Krull F, Dieset I, Mørch RH, Hope S, Gardsjord ES, Steen NE, Melle I, Brattbakk HR, Steen VM, Aukrust P, Djurovic S, Andreassen OA, Ueland T (2018)
    Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder
    Transl Psychiatry, 8 (1), 55
    DOI 10.1038/s41398-018-0102-1, PubMed 29507296
  6. Hoseth EZ, Krull F, Dieset I, Mørch RH, Hope S, Gardsjord ES, Steen NE, Melle I, Brattbakk HR, Steen VM, Aukrust P, Djurovic S, Andreassen OA, Ueland T (2018)
    Attenuated Notch signaling in schizophrenia and bipolar disorder
    Sci Rep, 8 (1), 5349
    DOI 10.1038/s41598-018-23703-w, PubMed 29593239
  7. Lyngstad SH, Gardsjord ES, Simonsen C, Engen MJ, Romm KL, Melle I, Færden A (2018)
    Consequences of persistent depression and apathy in first-episode psychosis - A one-year follow-up study
    Compr Psychiatry, 86, 60-66
    DOI 10.1016/j.comppsych.2018.07.015, PubMed 30081208
  8. Ringen PA, Faerden A, Antonsen B, Falk RS, Mamen A, Rognli EB, Solberg DK, Andreassen OA, Martinsen EW (2018)
    Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments
    Nord J Psychiatry, 72 (4), 296-302
    DOI 10.1080/08039488.2018.1449012, PubMed 29523041
  9. Ringen PA, Falk RS, Antonsen B, Faerden A, Mamen A, Rognli EB, Solberg DK, Martinsen EW, Andreassen OA (2018)
    Using motivational techniques to reduce cardiometabolic risk factors in long term psychiatric inpatients: a naturalistic interventional study
    BMC Psychiatry, 18 (1), 255
    DOI 10.1186/s12888-018-1832-6, PubMed 30111298
  10. Simonsen C, Faerden A, Ueland T, Vaskinn A, Bjella T, Andreassen O, Romm KL, Melle I (2018)
    Self-rated disability in first treated episode of psychosis: A 1-year follow-up study
    Compr Psychiatry, 85, 48-54
    DOI 10.1016/j.comppsych.2018.06.004, PubMed 29981504
  11. Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2018)
    Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication
    J Psychiatr Res, 106, 74-81
    DOI 10.1016/j.jpsychires.2018.09.014, PubMed 30292780
  12. Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2018)
    Response: Are thyroid abnormalities only related to antipsychotic treatment in patients with severe mental disorders?
    J Psychiatr Res, 117, 150
    DOI 10.1016/j.jpsychires.2018.11.012, PubMed 30454945
  13. Zuber V, Jönsson EG, Frei O, Witoelar A, Thompson WK, Schork AJ, Bettella F, Wang Y, Djurovic S, Smeland OB, Dieset I, Fanous AH, Desikan RS, Küry S, Bézieau S, Dale AM, Mills IG, Andreassen OA (2018)
    Identification of shared genetic variants between schizophrenia and lung cancer
    Sci Rep, 8 (1), 674
    DOI 10.1038/s41598-017-16481-4, PubMed 29330379
  14. Aas M, Dieset I, Mørch R, Steen NE, Hope S, Reponen EJ, Laskemoen JF, Ueland T, Aukrust P, Melle I, Agartz I, Andreassen OA (2018)
    Reduced brain-derived neurotrophic factor is associated with childhood trauma experiences and number of depressive episodes in severe mental disorders
    Schizophr Res, 205, 45-50
    DOI 10.1016/j.schres.2018.08.007, PubMed 30126813

Publications 2017

  1. Eriksen BMS, Bjørkly S, Lockertsen Ø, Færden A, Roaldset JO (2017)
    Low cholesterol level as a risk marker of inpatient and post-discharge violence in acute psychiatry - A prospective study with a focus on gender differences
    Psychiatry Res, 255, 1-7
    DOI 10.1016/j.psychres.2017.05.010, PubMed 28505467
  2. Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, Spigset O (2017)
    Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics
    Eur Psychiatry, 48, 71-78
    DOI 10.1016/j.eurpsy.2017.04.001, PubMed 29331603
  3. Gjerde PB, Dieset I, Simonsen C, Hoseth EZ, Iversen T, Lagerberg TV, Lyngstad SH, Mørch RH, Skrede S, Andreassen OA, Melle I, Steen VM (2017)
    Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis
    Schizophr Res, 197, 253-260
    DOI 10.1016/j.schres.2017.10.042, PubMed 29129510
  4. Hoseth EZ, Ueland T, Dieset I, Birnbaum R, Shin JH, Kleinman JE, Hyde TM, Mørch RH, Hope S, Lekva T, Abraityte AJ, Michelsen AE, Melle I, Westlye LT, Ueland T, Djurovic S, Aukrust P, Weinberger DR, Andreassen OA (2017)
    A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue
    Schizophr Bull, 43 (4), 881-890
    DOI 10.1093/schbul/sbw183, PubMed 28049760
  5. Iversen TSJ, Steen NE, Dieset I, Hope S, Mørch R, Gardsjord ES, Jørgensen KN, Melle I, Andreassen OA, Molden E, Jönsson EG (2017)
    Side effect burden of antipsychotic drugs in real life - Impact of gender and polypharmacy
    Prog Neuropsychopharmacol Biol Psychiatry, 82, 263-271
    DOI 10.1016/j.pnpbp.2017.11.004, PubMed 29122637
  6. Lockertsen Ø, Procter N, Vatnar SKB, Faerden A, Eriksen BMS, Roaldset JO, Varvin S (2017)
    Screening for risk of violence using service users' self-perceptions: A prospective study from an acute mental health unit
    Int J Ment Health Nurs, 27 (3), 1055-1065
    DOI 10.1111/inm.12413, PubMed 29171702
  7. Mørch RH, Dieset I, Faerden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Haram M, Falk RS, Joa I, Morken G, Agartz I, Aukrust P, Djurovic S, Melle I, Ueland T, Andreassen OA (2017)
    Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study
    Acta Psychiatr Scand, 136 (4), 400-408
    DOI 10.1111/acps.12783, PubMed 28815548
  8. Quintana DS, Dieset I, Elvsåshagen T, Westlye LT, Andreassen OA (2017)
    Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders
    Front Neuroendocrinol, 45, 1-10
    DOI 10.1016/j.yfrne.2016.12.004, PubMed 28049009
  9. Simonsen C, Faerden A, Romm KL, Berg AO, Bjella T, Sundet K, Ueland T, Andreassen O, Melle I (2017)
    Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up
    Psychiatry Res, 254, 118-125
    DOI 10.1016/j.psychres.2017.04.050, PubMed 28460281
  10. Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, Andreassen OA, Westlye LT, Melle I, Berg AO, Mørch-Johnsen L, Faerden A, Flyckt L, Fatouros-Bergman H, Karolinska Schizophrenia Project Consortium (KaSP), Jönsson EG et al. (2017)
    Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium
    Acta Psychiatr Scand, 135 (5), 439-447
    DOI 10.1111/acps.12718, PubMed 28369804
  11. Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, Andreassen OA, Westlye LT, Melle I, Berg AO, Morch-Johnsen L, Færden A, Flyckt L, Fatouros-Bergman H, Karolinska Schizophrenia Project Consortium (KaSP), Jönsson EG et al. (2017)
    Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium
    Psychol Med, 48 (1), 82-94
    DOI 10.1017/S0033291717001283, PubMed 28545597
  12. Aas M, Dieset I, Hope S, Hoseth E, Mørch R, Reponen E, Steen NE, Laskemoen JF, Ueland T, Aukrust P, Agartz I, Andreassen OA, Melle I (2017)
    Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses
    Brain Behav Immun, 65, 342-349
    DOI 10.1016/j.bbi.2017.06.005, PubMed 28619247

Publications 2016

  1. Dieset I (2016)
    Good meetings with patients
    Tidsskr. Nor. Laegeforen., 136 (18), 1593
  2. Dieset I, Andreassen OA, Haukvik UK (2016)
    Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span
    Schizophr Bull, 42 (6), 1316-1319
    DOI 10.1093/schbul/sbw028, PubMed 27033328
  3. Eriksen BMS, Bjorkly S, Faerden A, Friestad C, Hartvig P, Roaldset JO (2016)
    Gender Differences in the Predictive Validity of a Violence Risk Screening Tool: A Prospective Study in an Acute Psychiatric Ward
    Int. J. Forensic Ment. Health, 15 (2), 186-197
    DOI 10.1080/14999013.2016.1170740
  4. Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, Spigset O (2016)
    Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder
    J Clin Psychopharmacol, 36 (6), 615-620
    DOI 10.1097/JCP.0000000000000582, PubMed 27749681
  5. Fountoulakis KN, Chatzikosta I, Pastiadis K, Zanis P, Kawohl W, Kerkhof AJ, Navickas A, Höschl C, Lecic-Tosevski D, Sorel E, Rancans E, Palova E, Juckel G, Isacsson G, Jagodic HK, Botezat-Antonescu I, Rybakowski J, Azorin JM, Cookson J, Waddington J, Pregelj P, Demyttenaere K, Hranov LG, Stevovic LI, Pezawas L et al. (2016)
    Relationship of suicide rates with climate and economic variables in Europe during 2000-2012
    Ann Gen Psychiatry, 15, 19
    DOI 10.1186/s12991-016-0106-2, PubMed 27508001
  6. Kaiser S, Lyne J, Agartz I, Clarke M, Mørch-Johnsen L, Faerden A (2016)
    Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment
    Schizophr Res, 186, 39-45
    DOI 10.1016/j.schres.2016.07.013, PubMed 27453425
  7. Mørch RH, Dieset I, Færden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Joa I, Morken G, Agartz I, Aukrust P, Djurovic S, Melle I, Ueland T, Andreassen OA (2016)
    Inflammatory evidence for the psychosis continuum model
    Psychoneuroendocrinology, 67, 189-97
    DOI 10.1016/j.psyneuen.2016.02.011, PubMed 26923849
  8. Nerhus M, Berg AO, Kvitland LR, Dieset I, Hope S, Dahl SR, Weibell MA, Romm KL, Faerden A, Andreassen OA, Melle I (2016)
    Low vitamin D is associated with negative and depressive symptoms in psychotic disorders
    Schizophr Res, 178 (1-3), 44-49
    DOI 10.1016/j.schres.2016.08.024, PubMed 27595553
  9. Steen NE, Aas M, Simonsen C, Dieset I, Tesli M, Nerhus M, Gardsjord E, Mørch R, Agartz I, Melle I, Ueland T, Spigset O, Andreassen OA (2016)
    Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders
    World J Biol Psychiatry, 18 (6), 471-482
    DOI 10.1080/15622975.2016.1245441, PubMed 27712130
  10. Steen NE, Aas M, Simonsen C, Dieset I, Tesli M, Nerhus M, Gardsjord E, Mørch R, Agartz I, Melle I, Vaskinn A, Spigset O, Andreassen OA (2016)
    Serum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic setting
    Int J Bipolar Disord, 4 (1), 24
    DOI 10.1186/s40345-016-0067-z, PubMed 27858347
  11. Tesli M, Wirgenes KV, Hughes T, Bettella F, Athanasiu L, Hoseth ES, Nerhus M, Lagerberg TV, Steen NE, Agartz I, Melle I, Dieset I, Djurovic S, Andreassen OA (2016)
    VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls
    Br J Psychiatry, 209 (2), 114-20
    DOI 10.1192/bjp.bp.115.161950, PubMed 26941264
  12. Aas M, Andreassen OA, Aminoff SR, Færden A, Romm KL, Nesvåg R, Berg AO, Simonsen C, Agartz I, Melle I (2016)
    A history of childhood trauma is associated with slower improvement rates: Findings from a one-year follow-up study of patients with a first-episode psychosis
    BMC Psychiatry, 16, 126
    DOI 10.1186/s12888-016-0827-4, PubMed 27146044

Publications 2015

  1. Barrett EA, Mork E, Færden A, Nesvåg R, Agartz I, Andreassen OA, Melle I (2015)
    The development of insight and its relationship with suicidality over one year follow-up in patients with first episode psychosis
    Schizophr Res, 162 (1-3), 97-102
    DOI 10.1016/j.schres.2015.01.004, PubMed 25620119
  2. Berg AO, Barrett EA, Nerhus M, Büchman C, Simonsen C, Faerden A, Andreassen OA, Melle I (2015)
    Psychosis: clinical insight and beliefs in immigrants in their first episode
    Early Interv Psychiatry, 12 (2), 185-192
    DOI 10.1111/eip.12297, PubMed 26663787
  3. Hope S, Hoseth E, Dieset I, Mørch RH, Aas M, Aukrust P, Djurovic S, Melle I, Ueland T, Agartz I, Ueland T, Westlye LT, Andreassen OA (2015)
    Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls
    Schizophr Res, 165 (2-3), 188-94
    DOI 10.1016/j.schres.2015.04.004, PubMed 25956633
  4. Hoseth EZ, Westlye LT, Hope S, Dieset I, Aukrust P, Melle I, Haukvik UK, Agartz I, Ueland T, Ueland T, Andreassen OA (2015)
    Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls
    Acta Psychiatr Scand, 133 (1), 53-62
    DOI 10.1111/acps.12467, PubMed 26189721
  5. Mørch-Johnsen L, Nesvåg R, Faerden A, Haukvik UK, Jørgensen KN, Lange EH, Andreassen OA, Melle I, Agartz I (2015)
    Brain structure abnormalities in first-episode psychosis patients with persistent apathy
    Schizophr Res, 164 (1-3), 59-64
    DOI 10.1016/j.schres.2015.03.001, PubMed 25818626
  6. Steen NE, Aas M, Simonsen C, Dieset I, Tesli M, Nerhus M, Gardsjord E, Mørch R, Agartz I, Melle I, Vaskinn A, Spigset O, Andreassen OA (2015)
    Serum level of venlafaxine is associated with better memory in psychotic disorders
    Schizophr Res, 169 (1-3), 386-392
    DOI 10.1016/j.schres.2015.10.021, PubMed 26516101

Publications 2014

  1. Dieset I, Haukvik UK, Melle I, Røssberg JI, Ueland T, Hope S, Dale AM, Djurovic S, Aukrust P, Agartz I, Andreassen OA (2014)
    Association between altered brain morphology and elevated peripheral endothelial markers--implications for psychotic disorders
    Schizophr Res, 161 (2-3), 222-8
    DOI 10.1016/j.schres.2014.11.006, PubMed 25433965
  2. Haram M, Tesli M, Dieset I, Steen NE, Røssberg JI, Djurovic S, Andreassen OA, Melle I (2014)
    An attempt to identify single nucleotide polymorphisms contributing to possible relationships between personality traits and oxytocin-related genes
    Neuropsychobiology, 69 (1), 25-30
    DOI 10.1159/000356965, PubMed 24458227
  3. Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA (2014)
    Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions
    Front Psychiatry, 5, 137
    DOI 10.3389/fpsyt.2014.00137, PubMed 25309466
  4. Steen NE, Methlie P, Lorentzen S, Dieset I, Aas M, Nerhus M, Haram M, Agartz I, Melle I, Berg JP, Andreassen OA (2014)
    Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders
    J Psychiatr Res, 52, 57-62
    DOI 10.1016/j.jpsychires.2014.01.017, PubMed 24534618

Publications 2013

  1. Dieset I (2013)
    [I. Dieset replies]
    Tidsskr Nor Laegeforen, 133 (7), 732-3
    DOI 10.4045/tidsskr.13.0365, PubMed 23588165
  2. Dieset I (2013)
    Response to Li and Su letter
    Am J Psychiatry, 170 (5), 561
    DOI 10.1176/appi.ajp.2013.12121529r, PubMed 23632840
  3. Etain B, Aas M, Andreassen OA, Lorentzen S, Dieset I, Gard S, Kahn JP, Bellivier F, Leboyer M, Melle I, Henry C (2013)
    Childhood trauma is associated with severe clinical characteristics of bipolar disorders
    J Clin Psychiatry, 74 (10), 991-8
    DOI 10.4088/JCP.13m08353, PubMed 24229750
  4. Faerden A, Barrett EA, Nesvåg R, Friis S, Finset A, Marder SR, Ventura J, Andreassen OA, Agartz I, Melle I (2013)
    Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis
    Psychiatry Res, 210 (1), 55-61
    DOI 10.1016/j.psychres.2013.02.007, PubMed 23489592
  5. Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO, Agartz I, Aukrust P, Andreassen OA (2013)
    Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder
    Schizophr Res, 145 (1-3), 36-42
    DOI 10.1016/j.schres.2012.12.023, PubMed 23403415

Publications 2012

  1. Dieset I, Djurovic S, Tesli M, Hope S, Mattingsdal M, Michelsen A, Joa I, Larsen TK, Agartz I, Melle I, Røssberg JI, Aukrust P, Andreassen OA, Ueland T (2012)
    Up-regulation of NOTCH4 gene expression in bipolar disorder
    Am J Psychiatry, 169 (12), 1292-300
    DOI 10.1176/appi.ajp.2012.11091431, PubMed 23212060
  2. Dieset I, Hope S, Ueland T, Bjella T, Agartz I, Melle I, Aukrust P, Røssberg JI, Andreassen OA (2012)
    Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein
    Schizophr Res, 140 (1-3), 169-74
    DOI 10.1016/j.schres.2012.06.040, PubMed 22817875
  3. Langeveld J, Andreassen OA, Auestad B, Færden A, Hauge LJ, Joa I, Johannessen JO, Melle I, Rund BR, Røssberg JI, Simonsen E, Vaglum P, Larsen TK (2012)
    Is there an optimal factor structure of the Positive and Negative Syndrome Scale in patients with first-episode psychosis?
    Scand J Psychol, 54 (2), 160-5
    DOI 10.1111/sjop.12017, PubMed 23252448

Publications 2011

  1. Hope S, Dieset I, Agartz I, Steen NE, Ueland T, Melle I, Aukrust P, Andreassen OA (2011)
    Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia
    J Psychiatr Res, 45 (12), 1608-16
    DOI 10.1016/j.jpsychires.2011.08.003, PubMed 21889167

Publications 2010

  1. Barrett EA, Sundet K, Faerden A, Agartz I, Bratlien U, Romm KL, Mork E, Rossberg JI, Steen NE, Andreassen OA, Melle I (2010)
    Suicidality in first episode psychosis is associated with insight and negative beliefs about psychosis
    Schizophr Res, 123 (2-3), 257-62
    DOI 10.1016/j.schres.2010.07.018, PubMed 20685083
  2. Barrett EA, Sundet K, Faerden A, Nesvåg R, Agartz I, Fosse R, Mork E, Steen NE, Andreassen OA, Melle I (2010)
    Suicidality before and in the early phases of first episode psychosis
    Schizophr Res, 119 (1-3), 11-7
    DOI 10.1016/j.schres.2010.03.022, PubMed 20399077
  3. Faerden A, Finset A, Friis S, Agartz I, Barrett EA, Nesvåg R, Andreassen OA, Marder SR, Melle I (2010)
    Apathy in first episode psychosis patients: one year follow up
    Schizophr Res, 116 (1), 20-6
    DOI 10.1016/j.schres.2009.10.014, PubMed 19948392
  4. Nesvåg R, Lange EH, Faerden A, Barrett EA, Emilsson B, Ringen PA, Andreassen OA, Melle I, Agartz I (2010)
    The use of screening instruments for detecting alcohol and other drug use disorders in first-episode psychosis
    Psychiatry Res, 177 (1-2), 228-34
    DOI 10.1016/j.psychres.2010.01.007, PubMed 20178887
  5. Romm KL, Rossberg JI, Berg AO, Barrett EA, Faerden A, Agartz I, Andreassen OA, Melle I (2010)
    Depression and depressive symptoms in first episode psychosis
    J Nerv Ment Dis, 198 (1), 67-71
    DOI 10.1097/NMD.0b013e3181c81fc0, PubMed 20061872
  6. Sagen U, Faerden A, Haug T, Melle I, Finset A, Dammen T (2010)
    Are there common core features of apathy in different neuropsychiatric samples as assessed by the Apathy Evaluation Scale?
    Nord J Psychiatry, 64 (1), 49-57
    DOI 10.3109/08039480903274415, PubMed 19883192

Publications 2009

  1. Faerden A, Friis S, Agartz I, Barrett EA, Nesvåg R, Finset A, Melle I (2009)
    Apathy and functioning in first-episode psychosis
    Psychiatr Serv, 60 (11), 1495-503
    DOI 10.1176/ps.2009.60.11.1495, PubMed 19880468
  2. Faerden A, Vaskinn A, Finset A, Agartz I, Ann Barrett E, Friis S, Simonsen C, Andreassen OA, Melle I (2009)
    Apathy is associated with executive functioning in first episode psychosis
    BMC Psychiatry, 9, 1
    DOI 10.1186/1471-244X-9-1, PubMed 19133132
  3. Simonsen C, Sundet K, Vaskinn A, Birkenaes AB, Engh JA, Faerden A, Jónsdóttir H, Ringen PA, Opjordsmoen S, Melle I, Friis S, Andreassen OA (2009)
    Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group
    Schizophr Bull, 37 (1), 73-83
    DOI 10.1093/schbul/sbp034, PubMed 19443616

Publications 2008

  1. Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008)
    Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
    J Clin Psychopharmacol, 28 (2), 132-7
    DOI 10.1097/JCP.0b013e318166c4f7, PubMed 18344722
  2. Faerden A, Nesvåg R, Marder SR (2008)
    Definitions of the term 'recovered' in schizophrenia and other disorders
    Psychopathology, 41 (5), 271-8
    DOI 10.1159/000141921, PubMed 18594161
  3. Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Vaskinn A, Friis S, Opjordsmoen S, Andreassen OA (2008)
    The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness
    Acta Psychiatr Scand, 118 (4), 297-304
    DOI 10.1111/j.1600-0447.2008.01244.x, PubMed 18759810

Publications 2007

  1. Faerden A, Nesvåg R, Barrett EA, Agartz I, Finset A, Friis S, Rossberg JI, Melle I (2007)
    Assessing apathy: the use of the Apathy Evaluation Scale in first episode psychosis
    Eur Psychiatry, 23 (1), 33-9
    DOI 10.1016/j.eurpsy.2007.09.002, PubMed 18029152
  2. Ringen PA, Lagerberg TV, Birkenaes AB, Engn J, Faerden A, Jónsdottir H, Nesvåg R, Friis S, Opjordsmoen S, Larsen F, Melle I, Andreassen OA (2007)
    Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder
    Psychol Med, 38 (9), 1241-9
    DOI 10.1017/S003329170700236X, PubMed 18070373
  3. Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Jónsdóttir H, Nesvåg R, Vaskinn A, Friis S, Larsen F, Opjordsmoen S, Sundet K, Andreassen OA (2007)
    Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study
    Acta Psychiatr Scand, 117 (2), 133-8
    DOI 10.1111/j.1600-0447.2007.01135.x, PubMed 18081921

Publications 2006

  1. Haukvik UK, Dieset I, Bjøro T, Holte H, Fosså SD (2006)
    Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
    Ann Oncol, 17 (9), 1428-33
    DOI 10.1093/annonc/mdl149, PubMed 16831852

Publications 2001

  1. Faerden A (2001)
    [Rehabilitation of patients with chronic mental illness]
    Tidsskr Nor Laegeforen, 121 (29), 3375-9
    PubMed 11826780

Publications 1998

  1. Gjertsen MK, Bakka A, Buanes T, Rosseland A, Quist HL, Faerden A, Eriksen JA, Moller M, Baksaas I, Soreide O, Giercksky KE, Gaudernack G (1998)
    Intradermal ras peptide vaccines with GM-CSF as adjuvant
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 149-152

Publications 1995

  1. Faerden A, Waal H, Rønnow S (1995)
    [Long-term psychiatric patients in a sector of Oslo]
    Tidsskr Nor Laegeforen, 115 (29), 3638-41
    PubMed 8539723

 
Scroll to top